Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00056290
Status:
COMPLETED
Last Update Posted:
2010-11-11
First Post:
2003-03-10
Brief Title:
VEGF Gene Transfer for Diabetic Neuropathy
Sponsor:
Losordo Douglas MD
Organization:
Losordo Douglas MD
Study Overview
Official Title:
pVGI1 VEGF2 Gene Transfer for Diabetic Neuropathy
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
True
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This gene therapy study is being conducted to evaluate intramuscular gene transfer using VEGF Vascular Endothelial Growth Factor in patients with diabetic neuropathy in the legs This condition causes a decrease in feeling and sensation due to diabetes VEGF is DNA or genetic material that is injected into the muscles of the leg Once in the leg it has been shown to cause new blood vessels to grow under a variety of conditions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NIH 0104-467 | None | None | None |